Khiron Life Sciences (KHRNF) Stock Price, News & Analysis

Company Overview

Khiron Life Sciences Corp. is a Canadian medical cannabis company focused on developing, producing and distributing cannabis-based products for medical and wellness applications. The company has historically emphasized regulated medical cannabis markets rather than the recreational-use segment.

Khiron’s operations have included cultivation, processing and the sale of medical cannabis products, along with patient education and clinical services. Its portfolio has included medical cannabis products and the Kuida line of cannabidiol (CBD) consumer products. The company has also developed Zerenia clinics, which provide consultations and related services for patients seeking medical cannabis treatment.

Founded in 2012, Khiron built its business primarily in Latin America and Europe, with a particular focus on Colombia, Peru, Brazil, the United Kingdom and Germany. Alvaro Torres, a co-founder of the company, has served as its chief executive officer. Khiron’s operations and corporate status have changed over time, so historical descriptions may not reflect its current activities.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 168,014 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:KHRNF
• CIK: N/A
• Web: www.khiron.ca
• Phone: (702) 527-3564
• Fax: N/A
• Employees: 310
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A